Mathews, P., Saeed, M. A., Zaretsky, J. M., Bansal, D., Peng, B., Luo, J., Klette, J., Reimers, M. A., Pachynski, R. K. (2025). A phase 1b study of cabozantinib and nivolumab with abiraterone (CABIOS) in metastatic castration-sensitive prostate cancer (mCSPC): Updated safety, efficacy, and immunologic findings.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.186